Predictive Significance of T Cell Subset Changes During Ex�vivo Generation of Adoptive Cellular Therapy Products for the Treatment of Advanced Non‑small Cell Lung Cancer

Oncology Letters - Greece
doi 10.3892/ol.2019.10964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Tumour Infiltrating Lymphocyte -Adoptive Cell Therapy: The Emerging Importance of Clonal Neoantigen Targets for Next-Generation Products in Non-Small Cell Lung Cancer

Immuno-Oncology Technology
2019English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Prognostic Significance of Diabetes Mellitus in Locally Advanced Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Shifting the Paradigm for Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1999English

Comprehensive T Cell Repertoire Characterization of Non-Small Cell Lung Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy